Process Development for Production of Viral Vaccines and Vectors
Products
Information
Process Development for API Production, Fill/Finish and Secondary Packaging- Cell line development - Transfer of customer technologies -Upstream / Downstream -iCellis Fermenter: development of scalable upstream and downstream technologies for adherent cells with higher yield.Major advantage for development of safe live viral vaccines using non-tumorigenic cell lines - Formulation Development - Stability Evaluation - Process Development for API production- Development and qualification of own seed cell banks for vaccine manufacturing, GMP cell lines Vero and DF-1, Duck cell line (AGE-1) Contact us for more information
Available In
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
United StatesGermany
Categories
APIs (Active Pharmaceutical Ingredients)Contract Services - Contract ServicesBiopharmaceuticalsSera and VaccinesCell & Gene therapy
